Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib + Bevacizumab/Chemo in Advanced NSCLC
NCT00434226Phase 2Terminated
- Sponsor
- Genentech
- Start
- Mar 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sunitinib in non-small cell lung cancer (NSCLC), sponsored by Genentech. Started Mar 2007; status: terminated.
02
Drugs
sunitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00434226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434226.